Registry of Patients Undergoing Endoscopic Management of Pancreatic Fluid Collections
Summary
Acute pancreatitis is one of the most common gastrointestinal disorders requiring hospitalization worldwide. Pancreatic fluid collections can occur as a consequence of acute and chronic pancreatitis and can result in significant morbidity and mortality, including significant abdominal pain, gastric outlet obstruction, biliary obstruction, organ failure, persistent unwellness, infection and sepsis. Symptomatic pancreatic fluid collections require treatment, and endoscopic drainage is considered standard of care. The aim of this study is to evaluate the treatment outcomes in patients undergoing standard of care, endoscopic treatment of pancreatic fluid collections.
Detailed description
Acute pancreatitis has an annual incidence of 13-45 cases per 100,000 persons and is one of the most common gastrointestinal disorders requiring hospitalization worldwide. It leads to over a quarter of a million hospital admissions annually in the United States, and inpatient costs exceeding 2.5 billion US dollars. Pancreatic fluid collections can occur as a consequence of acute and chronic pancreatitis and can result in significant morbidity and mortality, including significant abdominal pain, gastric outlet obstruction, biliary obstruction, organ failure, persistent unwellness, infection and sepsis. Symptomatic pancreatic fluid collections require treatment, and endoscopic drainage is considered standard of care. Endoscopic treatment involves the drainage of the fluid collection into the stomach or duodenum by placement of metal or plastic stents. If clinically indicated, endoscopic necrosectomy is also performed, which is the removal of devitalized pancreatic tissue using the endoscope. Currently the treatment success rate of endoscopic treatment of pancreatic fluid collections exceeds 90%. The aim of this study is to evaluate the treatment outcomes in patients undergoing standard of care, endoscopic treatment of pancreatic fluid collections.
Arms & interventions
- ProcedureEndoscopic management of pancreatic fluid collections
Patients with pancreatic fluid collections will be undergoing EUS-guided drainage and/or endoscopic necrosectomy
Outcome measures
Primary
Treatment outcomes in patients undergoing endoscopic treatment of pancreatic fluid collections.
Treatment outcomes in patients undergoing endoscopic treatment of pancreatic fluid collections.
Time frame: 3 years
Secondary
Treatment success
Time frame: 6 months
Number and type of interventions performed
Time frame: 6 months
Need for surgical intervention
Time frame: 6 months
Technical success of endoscopic interventions in pancreatic fluid collections.
Time frame: 6 months
Inflammatory response and organ failure in patients undergoing endoscopic therapy for pancreatic fluid collections.
Time frame: 6 months
Disease-related adverse events
Time frame: 6 monthts
Procedure-related adverse events
Time frame: 6 months
Timing of intervention
Time frame: 6 months
Hounsfield units of the pancreatic fluid collection
Time frame: 6 months
Impact of partial versus full encapsulation of pancreatic fluid collections
Time frame: 6 months
Incidence of disconnected pancreatic duct syndrome and sequelae of disconnected pancreatic duct syndrome
Time frame: 3 years
Hospital admission
Time frame: 6 months
Disease recurrence
Time frame: 3 years
Diabetes
Time frame: 3 years
Exocrine pancreatic insufficiency
Time frame: 3 years
Eligibility criteria
Study locations (1)
Orlando Health
Orlando, Florida, 21806